Results for tag: "Postmyocardial Infarction Syndrome Drug"

The Postmyocardial Infarction Syndrome Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat postmyocardial infarction syndrome (PMIS), a condition that occurs after a heart attack. These drugs are used to reduce the risk of further heart damage, improve heart function, and reduce the risk of death. Commonly used drugs include beta-blockers, ACE inhibitors, angiotensin receptor blockers, and statins. Other treatments may include lifestyle changes, such as quitting smoking, exercising regularly, and eating a healthy diet. Companies in the Postmyocardial Infarction Syndrome Drug market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies produce a variety of drugs used to treat PMIS, including beta-blockers, ACE inhibitors, angiotensin receptor blockers, and statins. Show Less Read more